Future investigations should focus on delineating the precise molecular mechanisms by which CD9 governs mitochondrial function, and on assessing its evolutionary conservation in human sarcopenia as well as its potential as a novel biomarker or therapeutic target. The gene discussed is CD9; the disease is sarcopenia.